Product Code: ETC9951625 | Publication Date: Sep 2024 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United Kingdom (UK) Pertussis Market refers to the market for the diagnosis, treatment, and prevention of pertussis, commonly known as whooping cough, within the UK healthcare system. Pertussis is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis and primarily affects infants and young children. The market includes diagnostic tests such as PCR and serology, vaccines for prevention, and medications for symptomatic treatment. Key players in the UK market include pharmaceutical companies, diagnostic test manufacturers, and healthcare providers. Factors driving market growth include increasing awareness about the importance of vaccination, government initiatives for immunization programs, and the rising incidence of pertussis cases. However, challenges such as vaccine hesitancy and limited access to healthcare services in remote areas can hinder market growth.
In the United Kingdom, the Pertussis (whooping cough) market is experiencing a growing demand for vaccinations and awareness campaigns due to the recent increase in reported cases. The market is witnessing a shift towards improved diagnostics for early detection and treatment of pertussis, driving the demand for advanced testing kits and diagnostic tools. Pharmaceutical companies are focusing on developing more effective vaccines and medications to control the spread of the disease and reduce its severity. Additionally, there is a rising trend of public health initiatives and government interventions to promote vaccination programs and raise awareness about pertussis prevention among healthcare professionals and the general population. Overall, the UK pertussis market is expected to continue growing as stakeholders work towards reducing the burden of this contagious respiratory infection.
In the United Kingdom (UK) Pertussis Market, several challenges are faced, including limited awareness among the public about the importance of vaccination against pertussis, leading to suboptimal vaccination rates and higher disease prevalence. There is also a need for improved diagnostic capabilities to accurately identify pertussis cases, as the symptoms of the disease can be similar to other respiratory illnesses. Additionally, the availability and affordability of pertussis vaccines may pose challenges in reaching all segments of the population. Furthermore, the emergence of new pertussis strains and the potential for waning immunity in vaccinated individuals highlight the need for ongoing research and development efforts to enhance vaccine effectiveness and coverage. Addressing these challenges will be crucial in effectively managing and reducing the burden of pertussis in the UK.
The United Kingdom (UK) Pertussis Market presents various investment opportunities for companies involved in the development and distribution of pertussis vaccines and diagnostic tests. With increasing awareness about the importance of vaccination and the rising prevalence of pertussis cases in the UK, there is a growing demand for improved vaccines and diagnostic solutions. Investing in research and development to create more effective and efficient pertussis vaccines, as well as innovative diagnostic tools for early detection, can be lucrative in this market. Additionally, partnerships with healthcare providers and government agencies to promote vaccination campaigns and improve access to pertussis vaccines can also be a strategic investment opportunity in the UK Pertussis Market.
The UK government has implemented several policies related to the Pertussis (whooping cough) market to control and prevent the spread of the disease. These policies include the National Health Service (NHS) vaccination program, which provides pertussis vaccines to infants and pregnant women to reduce the incidence of the disease. The government also conducts surveillance and monitoring of pertussis cases to track outbreaks and inform public health interventions. Additionally, there are regulations in place to ensure the safety and efficacy of pertussis vaccines available in the market. These policies aim to protect the population from pertussis infection, reduce healthcare costs associated with treating the disease, and ultimately improve public health outcomes in the UK.
The future outlook for the United Kingdom (UK) pertussis market is expected to remain positive, driven by increasing awareness about the disease and the importance of vaccination. With ongoing efforts to improve immunization rates and access to vaccines, the market is likely to witness steady growth in the coming years. The introduction of new and improved vaccines, along with advancements in diagnostic technologies, will further contribute to the market expansion. Additionally, the rising prevalence of pertussis among infants and young children underscores the need for effective prevention and treatment options, thereby creating opportunities for market players to develop innovative solutions. Overall, the UK pertussis market is poised for growth as healthcare stakeholders continue to prioritize disease prevention and control strategies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Pertussis Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Pertussis Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Pertussis Market - Industry Life Cycle |
3.4 United Kingdom (UK) Pertussis Market - Porter's Five Forces |
3.5 United Kingdom (UK) Pertussis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United Kingdom (UK) Pertussis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United Kingdom (UK) Pertussis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Pertussis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 United Kingdom (UK) Pertussis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Pertussis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Kingdom (UK) Pertussis Market Trends |
6 United Kingdom (UK) Pertussis Market, By Types |
6.1 United Kingdom (UK) Pertussis Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Pertussis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United Kingdom (UK) Pertussis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.1.4 United Kingdom (UK) Pertussis Market Revenues & Volume, By Chest X-Ray, 2021- 2031F |
6.1.5 United Kingdom (UK) Pertussis Market Revenues & Volume, By Nose or Throat Culture & Test, 2021- 2031F |
6.1.6 United Kingdom (UK) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Pertussis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Pertussis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United Kingdom (UK) Pertussis Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.4 United Kingdom (UK) Pertussis Market Revenues & Volume, By Supportive Treatments, 2021- 2031F |
6.2.5 United Kingdom (UK) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Pertussis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Pertussis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Pertussis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United Kingdom (UK) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Pertussis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Pertussis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Pertussis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United Kingdom (UK) Pertussis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United Kingdom (UK) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Pertussis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Pertussis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United Kingdom (UK) Pertussis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United Kingdom (UK) Pertussis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Pertussis Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Pertussis Market Export to Major Countries |
7.2 United Kingdom (UK) Pertussis Market Imports from Major Countries |
8 United Kingdom (UK) Pertussis Market Key Performance Indicators |
9 United Kingdom (UK) Pertussis Market - Opportunity Assessment |
9.1 United Kingdom (UK) Pertussis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United Kingdom (UK) Pertussis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United Kingdom (UK) Pertussis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Pertussis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 United Kingdom (UK) Pertussis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Pertussis Market - Competitive Landscape |
10.1 United Kingdom (UK) Pertussis Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Pertussis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |